J.S. v. Medica Health Care Plans (Docket No. M-12-1544)

The enrollee requested a formulary exception for Percocet (oxycodone/acetaminophen). The ALJ denied the exception because the prescriber hadn't documented why Percocet specifically — rather than a formulary alternative — was needed for this patient's condition, and the Council affirmed that denial.ruleHHS Departmental Appeals Board, Medicare Appeals Council — J.S. v. Medica Health Care Plans, Docket No. M-12-1544 (June 5, 2012)

A formulary exception doesn't turn on whether the requested drug would work — it turns on whether the prescriber's own statement specifically explains why the formulary alternative wouldn't work as well or would cause adverse effects for this patient. A general "this drug is needed" statement isn't the same thing.

This is exactly the gap a generic exception request tends to leave open: naming the drug without naming why the specific alternative the plan offers instead falls short for this patient. The prescriber's supporting statement is the one document that can close that gap, and it has to actually say so, not just request the drug.

Medicare Appeals Council decisions are published by HHS's own Departmental Appeals Board and are publicly citable — a real, verifiable body of precedent, the same as the Medicare Advantage decisions this product already cites for that pack.

Even a losing decision like this one is worth reading before filing an exception request, not after — it shows exactly what a plan and a reviewer expect the prescriber's own statement to say, which is the single best way to avoid the same outcome.

This case also illustrates a real, common pattern: the enrollee's request itself was reasonable, but the paperwork behind it didn't do the specific job the rule requires. That's a fixable gap, not a sign the underlying medical need was wrong.

A tiering exception for a specific drug like Percocet turns on a comparison, not just a statement of need — the prescriber's own statement has to explain specifically why a formulary alternative at a lower tier wouldn't work as well or would cause adverse effects for this patient, not simply that the requested drug is effective.